Wang Wentao, China's Minister of Commerce, reportedly met consecutively with CEOs of global pharmaceutical companies, including Eli Lilly, on the 21st to request expanded investment, the Ministry of Commerce announced on the 22nd.


According to the Ministry of Commerce and foreign media such as Bloomberg News, Minister Wang met with David Ricks, CEO of Eli Lilly, in Beijing on the same day, urging him to increase investment and provide more high-quality pharmaceuticals and services in China.


In response, CEO Ricks said, "We consider the Chinese market very important," and promised, "We will strengthen our research and development efforts within China."


Wang Wentao, Chinese Minister of Commerce. <br>Photo by Reuters Yonhap News

Wang Wentao, Chinese Minister of Commerce.
Photo by Reuters Yonhap News

View original image

The meeting between the two took place amid calls within the U.S. Congress to sanction the Chinese biotechnology company WuXi AppTec.


It is known that a significant portion of the active ingredient in Eli Lilly's obesity treatment drug, Zepbound, is produced by WuXi AppTec.


Minister Wang also met with Enrique Lores, CEO of Hewlett-Packard (HP), urging innovation and expanded investment in China.



At a meeting with CEO Ola K?llenius, he also advised seizing opportunities in China's digital development.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing